Literature DB >> 264606

Residual acid maltase activity in late-onset acid maltase deficiency.

M Mehler, S DiMauro.   

Abstract

Residual acid maltase activity was found by a sensitive fluorometric assay in muscle biopsies from 15 patients with late-onset acid maltase deficiency (mean, 6.91 percent; range, 2.4 to 12.2) but not in biopsy or autopsy muscle from three patients with the infantile form. Electrophoresis, kinetic characteristics, and subcellular fractionation indicated that the residual activity was lysosomal acid maltase and not a contaminating isozyme of neutral maltase. There was no correlation between the amount of residual acid maltase activity and the severity of the clinical picture or glycogen accumulation. The presence of acid maltase activity in muscle, liver, and, to a greater extent, leukocytes in late-onset but not infantile acid maltase deficiency and the failure of the two disease forms to occur in the same family suggest that they are genetically distinct.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 264606     DOI: 10.1212/wnl.27.2.178

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  26 in total

1.  Acid maltase deficiency: a case study and review of the pathophysiological changes and proposed therapeutic measures.

Authors:  H Isaacs; N Savage; M Badenhorst; T Whistler
Journal:  J Neurol Neurosurg Psychiatry       Date:  1986-09       Impact factor: 10.154

2.  Identification of a missense mutation in one allele of a patient with Pompe disease, and use of endonuclease digestion of PCR-amplified RNA to demonstrate lack of mRNA expression from the second allele.

Authors:  N Zhong; F Martiniuk; S Tzall; R Hirschhorn
Journal:  Am J Hum Genet       Date:  1991-09       Impact factor: 11.025

3.  Extensive genetic heterogeneity in patients with acid alpha glucosidase deficiency as detected by abnormalities of DNA and mRNA.

Authors:  F Martiniuk; M Mehler; S Tzall; G Meredith; R Hirschhorn
Journal:  Am J Hum Genet       Date:  1990-07       Impact factor: 11.025

4.  Adult and infantile glycogenosis type II in one family, explained by allelic diversity.

Authors:  L H Hoefsloot; A T van der Ploeg; M A Kroos; M Hoogeveen-Westerveld; B A Oostra; A J Reuser
Journal:  Am J Hum Genet       Date:  1990-01       Impact factor: 11.025

5.  Prospect for enzyme therapy in glycogenosis II variants: a study on cultured muscle cells.

Authors:  A T van der Ploeg; P A Bolhuis; R A Wolterman; J W Visser; M C Loonen; H F Busch; A J Reuser
Journal:  J Neurol       Date:  1988-09       Impact factor: 4.849

6.  Biochemical, immunological, and cell genetic studies in glycogenosis type II.

Authors:  A J Reuser; J F Koster; A Hoogeveen; H Galjaard
Journal:  Am J Hum Genet       Date:  1978-03       Impact factor: 11.025

7.  [Mitigated adult forms of acid maltase deficiency (Pompe's disease). Morphologic and pathobiochemical studies].

Authors:  D Pongratz; G Hübner; T Deufel; O H Wieland
Journal:  Klin Wochenschr       Date:  1983-08-01

8.  Leaky splicing mutation in the acid maltase gene is associated with delayed onset of glycogenosis type II.

Authors:  C F Boerkoel; R Exelbert; C Nicastri; R C Nichols; F W Miller; P H Plotz; N Raben
Journal:  Am J Hum Genet       Date:  1995-04       Impact factor: 11.025

9.  Acid alpha-glucosidase deficiency: identification and expression of a missense mutation (S529V) in a Japanese adult phenotype.

Authors:  H Tsunoda; T Ohshima; J Tohyama; M Sasaki; N Sakuragawa; F Martiniuk
Journal:  Hum Genet       Date:  1996-04       Impact factor: 4.132

10.  Isolation of a cDNA for human acid alpha-glucosidase and detection of genetic heterogeneity for mRNA in three alpha-glucosidase-deficient patients.

Authors:  F Martiniuk; M Mehler; A Pellicer; S Tzall; G La Badie; C Hobart; A Ellenbogen; R Hirschhorn
Journal:  Proc Natl Acad Sci U S A       Date:  1986-12       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.